Our Mission

Our Mission

The Joint Breast Cancer Registry (JBCR) is dedicated to fostering global partnerships and facilitating high-impact scientific collaborations. By leveraging comprehensive real-world evidence, we aim to deepen the collective understanding of breast cancer biology, epidemiology, treatment modalities, and clinical outcomes. Through these efforts, we provide the foundational data necessary to advance oncology research and improve patient care standards in Singapore and the region.

Our Vision

We envision a future where the registry serves as a primary driver for data-driven healthcare, focusing on three core pillars:

• Clinical Excellence: Equipping clinicians with evidence-based, personalised medicine approaches to enhance the delivery of value-driven care and improve long-term survivorship. 
• Patient Empowerment: Providing the insights needed for individual patients to participate meaningfully in shared treatment decision-making. 
• Strategic Leadership: Empowering healthcare leaders and policymakers to make informed, data-driven decisions that shape national breast cancer programmes and optimise resource allocation.

Strategic Impact

Drawing from our extensive repository of patient data treated since 1990, the registry supports mission-critical research areas:

• Translational Insights: Bridging the gap between clinical trial results and real-world outcomes. 
• Personalised Medicine: Informing treatment strategies through high-granularity analysis of ethnic disparities in treatment responses and side effects. 
• Healthcare Evaluation: Benchmarking local outcomes against global healthcare performance indicators to ensure world-class care standards.